Achilles Therapeutics UK Limited

Achilles Therapeutics UK Limited specialises in developing personalised cancer immunotherapy approaches that target tumour-specific mutations. The organisation focuses on creating individualised treatment strategies based on each patient's unique tumour genomic profile, utilising advanced sequencing technologies to identify clonal neoantigens present across all cancer cells within a tumour.

• Tumour Neoantigen Targeting
• Clonal Mutation Analysis
• Patient-Specific Therapeutic Design

The therapeutic strategy emphasises precision medicine principles, developing treatments tailored to the molecular characteristics of individual malignancies rather than employing standardised protocols.